SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells
Robert W. Brooks(Scripps Research Institute), William G. Kerr(Amicus Therapeutics (United Kingdom))
Cited by 142
Related Papers
Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
|Molecular Medicine|2011|112
Discovery of a novel SHIP1 agonist that promotes degradation of lipid-laden phagocytic cargo by microglia
|iScience|2022|28
Microglial lipid phosphatase SHIP1 limits complement-mediated synaptic pruning in the healthy developing hippocampus
|Immunity|2024|25
LRBA is Essential for Allogeneic Responses in Bone Marrow Transplantation
|Scientific Reports|2016|12